Benjamin Linas, MD
Associate Professor
Boston University School of Medicine
Dept of Medicine
Infectious Diseases Section

MD, New York University School of Medicine
MPH, Harvard School of Public Health



Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Associate Professor
Boston University School of Public Health
Epidemiology





A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs
09/01/2016 - 07/31/2021 (PI)
Trustees of Columbia University NIH-NIDA

Lifespan/Tufts/brown Center for AIDS Research (CFAR): Core B Developmental (Pilot Projects)
07/01/2016 - 06/30/2018 (PI)
Miriam Hospital NIH-NIAID

Strategic Timing of Antiretroviral Treatment (START) - INSIGHT
12/01/2010 - 05/31/2018 (PI)
Institute for Clinical Research, Inc. NIH-NIAID

Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health..
07/01/2015 - 04/30/2018 (PI)
Cornell University NIH-NIDA

Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs
02/15/2015 - 01/31/2018 (PI)
Cornell University NIH-NIDA

Economic Modeling for HIV, Viral Hepatitis, STD, TB and School Health
09/30/2014 - 09/29/2017 (PI)
Harvard School of Public Health CDC

Intensive Models of HCV Care for Injection Drug Users
07/15/2012 - 06/30/2017 (PI)
AlbertEinsteinCllgeOfMed of Yeshiva U. NIH-NIDA

Simulation Modeling to Improve HIV/HCV Screening, Treatment & Care - Supplement
06/01/2014 - 05/31/2017 (PI)
NIH-NIDA
5R01DA031059-04

Simulation Modeling to Improve HIV/HCV Screening, Treatment & Care
06/15/2012 - 05/31/2017 (PI)
NIH-NIDA
5R01 DA031059-04

The Economic Burden of HIV and HCV Infection in Hospitalized Inmates
02/01/2016 - 01/31/2017 (PI)
Miriam Hospital NIH-NIAID

Showing 10 of 13 results. Show All Results


Yr Title Project-Sub Proj Pubs
2017 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-03-6229 1
2016 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-02-6229 1
2015 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 1P30DA040500-01-6229 1
2014 Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care 3R01DA031059-03S1 13
2014 Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care 5R01DA031059-03 13
2013 Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care 5R01DA031059-02 13
2012 Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care 1R01DA031059-01A1 13
2011 Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs 5K01AI073193-05 6
2010 Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs 5K01AI073193-04 6
2009 Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs 5K01AI073193-03 6
Showing 10 of 12 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Cohen GH, Tamrakar S, Lowe S, Sampson L, Ettman C, Linas B, Ruggiero K, Galea S. Comparison of Simulated Treatment and Cost-effectiveness of a Stepped Care Case-Finding Intervention vs Usual Care for Posttraumatic Stress Disorder After a Natural Disaster. JAMA Psychiatry. 2017 Oct 04.View Related Profiles. PMID: 28979968.
  2. Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J Subst Abuse Treat. 2017 Jul 03.View Related Profiles. PMID: 28733097.
  3. Losina E, Hyle EP, Borre ED, Linas BP, Sax PE, Weinstein MC, Rusu C, Ciaranello AL, Walensky RP, Freedberg KA. Projecting 10-yr, 20-yr and Lifetime Risks of Cardiovascular Disease in Persons Living with HIV in the US. Clin Infect Dis. 2017 Jun 12. PMID: 28605504.
  4. Barocas JA, Beiser M, León C, Gaeta JM, O''Connell JJ, Linas BP. Experience and Outcomes of Hepatitis C Treatment in a Cohort of Homeless and Marginally Housed Adults. JAMA Intern Med. 2017 Jun 01; 177(6):880-882.View Related Profiles. PMID: 28395004; DOI: 10.1001/jamainternmed.2017.0358;.
  5. Linas BP, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1. Open Forum Infect Dis. 2017; 4(1):ofw266.View Related Profiles. PMID: 28480259.
  6. Barocas JA, Linas BP. Editorial Commentary: Decision Science at Work: The Case of Hepatitis C Virus Postexposure Prophylaxis. Clin Infect Dis. 2017 Jan 01; 64(1):100-101. PMID: 27815292.
  7. Linas BP. Understanding Cost and Value in Hepatitis C Therapy. Top Antivir Med. 2016 Jul/Aug; 24(2):93-97. PMID: 27841979.
  8. Freiman JM, Tran TM, Schumacher SG, White LF, Ongarello S, Cohn J, Easterbrook PJ, Linas BP, Denkinger CM. Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis. Ann Intern Med. 2016 Sep 06; 165(5):345-55.View Related Profiles. PMID: 27322622; DOI: 10.7326/M16-0065;.
  9. Barocas JA, Linas BP, Kim AY, Fangman J, Westergaard RP. Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs. Open Forum Infect Dis. 2016 Mar; 3(2):ofw075. PMID: 27191007; DOI: 10.1093/ofid/ofw075;.
  10. Carey KJ, Huang W, Linas BP, Tsui JI. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders. J Subst Abuse Treat. 2016 Jul; 66:54-9. PMID: 26988423; DOI: 10.1016/j.jsat.2016.01.009;.
Showing 10 of 36 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 36 publications over 13 distinct years, with a maximum of 8 publications in 2014

YearPublications
19971
19981
20002
20062
20092
20101
20111
20121
20132
20148
20155
20166
20174
Contact for Mentoring:


771 Albany St
Boston MA 02118
Google Map


Linas's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department